Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.20
-0.07 (-0.53%)
Aug 25, 2025, 3:37 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Laboratory Solutions | 4.61B | Log In | Log In | Log In | Log In | Upgrade |
Laboratory Solutions Growth | -3.65% | Log In | Log In | Log In | Log In | Upgrade |
Bioscience Production | 2.17B | Log In | Log In | Log In | Log In | Upgrade |
Bioscience Production Growth | 0.47% | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Materials & Consumables | - | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Materials & Consumables Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Third Party Materials & Consumables | - | Log In | Log In | Log In | Log In | Upgrade |
Third Party Materials & Consumables Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Services & Specialty Procurement | - | Log In | Log In | Log In | Log In | Upgrade |
Services & Specialty Procurement Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Equipment & Instrumentation | - | Log In | Log In | Log In | Log In | Upgrade |
Equipment & Instrumentation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Americas Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Americas Adjusted EBITDA | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Adjusted EBITDA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Adjusted EBITDA | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Adjusted EBITDA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA Adjusted EBITDA | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA Adjusted EBITDA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted EBITDA | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted EBITDA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Americas | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA | - | Log In | Log In | Log In | Log In | Upgrade |
AMEA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Laboratory Solutions Adjusted Operating Income | 598.00M | Log In | Log In | Log In | Log In | Upgrade |
Laboratory Solutions Adjusted Operating Income Growth | -11.66% | Log In | Log In | Log In | Log In | Upgrade |
Bioscience Production Adjusted Operating Income | 558.20M | Log In | Log In | Log In | Log In | Upgrade |
Bioscience Production Adjusted Operating Income Growth | -2.99% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted Operating Income | -66.40M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted Operating Income Growth | 17.51% | Log In | Log In | Log In | Log In | Upgrade |